Recently Added |View All
Temple Lung Center | Enrolling Clinical Trials
The Temple Lung Center conducts one of the most comprehensive lung disease clinical trials programs in the country. Our advancements in basic, translational and clinical research are changing lung disease treatment. By pioneering effective ...
Optimizing Treatment for CTD-ILD
When autoimmune or connective tissue diseases cause inflammation or scarring of the lungs, both diagnosis and effective management can be challenging.
Diagnosis and Treatment of Obesity-Hypoventilation Syndrome
Obesity hypoventilation syndrome (OHS) is a respiratory disorder resulting in multisystem dysfunction. This program will review the epidemiology, pathophysiology, and mortality of this disorder. Current treatment recommendations as put ...
"COVID pneumonia represents the active inflammation of the pulmonary parenchyma that is caused by SARS-CoV-2, the coronavirus that has caused the COVID-19 pandemic. Millions of patients have been affected worldwide and hospitalizations ...
Recognizing and Treating Tracheobronchomalacia
"Tracheobronchomalacia (TBM) is an under-recognized cause of shortness of breath, recurrent respiratory infections and chronic coughing. It involves collapse of the main airways, due to a weakness of the cartilage and/or floppiness of ...
Bronchoscopic Lung Volume Reduction in Patients with Advanced Emphysema
As part of the Pulmonology On Air 2022 Global Event, Gerard Criner, MD, FACP, FACCP, Director of the Temple Lung Center, demonstrates a LIVE endobronchial valve placement on a patient with advanced homogenous emphysema.
GOLD International COPD Conference
Join us in person or online for an international comprehensive educational symposium on chronic obstructive pulmonary disease (COPD). This is the seventh consecutive year for this one-day COPD conference. Wednesday, November 16, 2022 from 8:00 AM – 6:00 PM EST
As the nation’s leading COPD research and treatment center, Temple sets new standards for COPD care.
Management of Early Stage Non-Small Cell Lung Cancer
Presented by Fox Chase Cancer Center, the Temple Lung Center, and the Temple Health Office for Continuing Medical Education, this conference is designed as a forum for discussion of advances in technology and treatment of early stage non-small ...
While many cases of asthma can be managed in a primary care setting, 5–10% of patients have asthma that cannot be controlled by standard treatments.
Broncoscopic Lung Volume Reduction Physician Fact Sheet
For patients with emphysema and severe hyperinflation whose symptoms cannot be managed using medication or oxygen therapy alone, doctors may resort to surgical resection of the worse regions of emphysema to reduce air trapping and improve patient outcomes
Temple Lung Center Physician Guide
Thanks to our collaboration with physicians like you, we are now one of the largest pulmonary centers in the region (over 32,000 patient visits per year). We also perform 13,000 pulmonary function tests and 1,000 bronchoscopies every year.
Lung Transplant Program Referral Information
The Temple Lung Transplant Program is a leader in both quantity and quality. It’s the nation’s highest volume program, but it also has the best one-year survival rates in Philadelphia and all of Pennsylvania.
Bernard is a 37-year-old man with sarcoidosis initially diagnosed by lung biopsy in 2009. The sarcoidosis affects his skin, lungs, lymph nodes, and liver. He was referred to the Temple Lung Center for a lung transplantation evaluation ...
Interstitial Lung Disease Program Referral Information
Patients with interstitial lung disease require care from a multidisciplinary team of experienced physicians, an active research program, and a commitment to patient education. The Temple Lung Center’s Interstitial Lung Disease Program ...
Tracheobronchial Malacia Referral Information
The Tracheobronchomalacia (TBM) Program at the Temple Lung Center offers patients with this rare and often under-recognized condition, a multidisciplinary medical team led by specialty-trained thoracic surgeon Charles Bakhos, MD, FACS.
The Potential for Bronchoscopic Interventions in Chronic Bronchitis
Chronic bronchitis is a clinical diagnosis characterized by chronic cough and phlegm production. It is typically associated with cigarette smoking and puts individuals at risk for respiratory exacerbations, reduces health related quality ...
Alpha-One Antitrypsin Deficiency and Ascending Aortic Distention
Friederich Kueppers, MD discusses a study indicating a link between Alpha-One Antitrypsin Deficiency and Aortic Aneurysm.
Pulmonary Hypertension: An update on diagnosis, treatment and risk assessment
Pulmonary hypertension encompasses a broad scope of disease states. This program will focus on pulmonary arterial hypertension (PAH) which begins as a vasculopathy within the small pulmonary arteries.
Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC) Disease
Non-tuberculous mycobacteria (NTM), particularly Mycobacterium avium complex (MAC), has become increasingly more prevalent in patients causing pulmonary dysfunction.